Symbols

INGN

Inogen·NASDAQ

--(--)

INGN fundamentals

INGN Q4 2025 Earnings

Inogen (INGN) released its earnings on Feb 24, 2026: revenue was 81.72M (YoY +2.05%), missed estimates; EPS was -0.26 (YoY +36.59%), beat estimates.

Revenue / YoY

81.72M

+2.05%

EPS / YoY

-0.26

+36.59%

Report date

Feb 24, 2026

INGN Earnings Call Summary for Q4,2025

Revenue Recovery: Full-year 2025 revenue growth of 4%, with Q4 unit volumes up 20% YoY.
Profitability Milestone: First positive adjusted EBITDA ($2.7M) since 2021, net loss reduced 61%.
Innovation Surge: $6M+ in Simeox sales, Voxi 5 early traction, and Aurora masks targeting $2.2B market.
Share Buyback: $30M authorized to capitalize on undervalued shares.
2026 Outlook: 6% revenue growth guidance, with focus on B2B POC and new product launches.

Earnings

EPS

Revenue

Revenue & Expenses

INGN has released its 2025 Q4 earnings report, with revenue of 81.72M, reflecting a YoY change of 2.05%, and net profit of -7.13M, showing a YoY change of 26.96%. The Sankey diagram below clearly presents INGN's revenue sources and cost distribution.

Key Indicators

Inogen (INGN) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Inogen (INGN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Inogen (INGN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Inogen (INGN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown